483 Nesher Pharmaceuticals (USA) May 2015

483 Nesher Pharmaceuticals (USA) May 2015

Robert Ham FDA, Michele Perry Williams FDA, Michele Perry-Williams FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued 1 inspectional observation (via FDA 483) on 07 May 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 07 May 2015
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart